11,467 reports of suspected adverse vaccination reactions evaluated
Change in procedure for Project Orbis: Swissmedic information requests now to be sent exclusively to the applicant in Switzerland
Simplification of the procedure for “ex officio" temporary authorisation
10,842 reports of suspected adverse vaccination reactions evaluated
Swissmedic supports the ICH’s ongoing development into a global initiative
Healthcare professionals can now use their Healthcare Professional Identity (hp-id) to access ElViS
The Consortium’s medicines regulators will only authorize medicines for COVID-19 if their clinical benefits outweigh their risks.
(OMS-Organisations Management System)
Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products
Comirnaty® approved for children aged 5 years and older – roughly a year after the initial authorisation for adults
12 individual substances and one substance group added to the Narcotics List
Ten years ago, Switzerland was one of the first states to sign the Medicrime Convention.
Eingabefrist: 21. Januar 2022
10,386 reports of suspected adverse vaccination reactions evaluated
The seven-strong Agency Council is Swissmedic's supervisory body
9,834 reports of suspected adverse vaccination reactions evaluated
The new guidance document is valid with effect from 1 November 2021.
Vaccine candidate CVnCoV no longer in rolling review procedure
Last modification 19.04.2021